APOA1 and neoplasm: Tumor size has been demonstrated as an independent predictor of recurrence in PTC in previous study (tumors > 2 cm associated with higher risk of recurrence than those ≤2 cm), [15] which indicates Apo-A1 is an protective biomarkers for male PTC patients.